Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile
- 29 February 2008
- journal article
- Published by Elsevier BV in Steroids
- Vol. 73 (2), 222-231
- https://doi.org/10.1016/j.steroids.2007.10.003
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- High-dose pilot study with the novel progestogen dienogestin patients with endometriosisGynecological Endocrinology, 2006
- New ProgestogensDrugs & Aging, 2004
- Stabilization of androgen receptor protein is induced by agonist, not by antagonistsBiochemical and Biophysical Research Communications, 2002
- The Tamoxifen-responsive Estrogen Receptor α Mutant D351Y Shows Reduced Tamoxifen-dependent Interaction with Corepressor ComplexesOnline Journal of Public Health Informatics, 2001
- Carbohydrate Metabolism during Treatment of Endometriosis with the Progestin Dienogest *)Experimental and Clinical Endocrinology & Diabetes, 1989
- Pharmacokinetics of the Progestin Dienogest (STS 557) in Rabbits*)Experimental and Clinical Endocrinology & Diabetes, 1989
- DOSAGE‐RELATED EFFECTS OF DANAZOL ON SEX HORMONE BINDING GLOBULIN AND FREE AND TOTAL ANDROGEN LEVELSClinical Endocrinology, 1986
- Receptor Binding of STS 5573)Experimental and Clinical Endocrinology & Diabetes, 1983
- The significance of drug interactions with human TBGg and CBG under physiological conditions: A new approachJournal of Steroid Biochemistry, 1981
- Measurement of the testosterone binding parameters for both testosterone-estradiol binding globulin and albumin in individual serum samplesSteroids, 1979